Home » Topics » Medical devices and technologies » Diagnostics

Diagnostics
RSS

NDA filed for ultrasound contrast agent

Sep. 13, 1996

DNA diagnostic for hereditary hemochromatosis

Sep. 13, 1996

MRI contrast agent from Advanced Magnetics cleared for launch

Sep. 6, 1996

Agreement reached on tests for hepatitis C virus

Sep. 6, 1996

Assays for the diagnosis of Alzheimer's disease

Sep. 6, 1996

ImaRx issued U.S. patent for contrast agents

Aug. 30, 1996

Theratech describes new rheumatiod arthritis diagnosis

Aug. 30, 1996

Sonus regains EchoGen European marketing rights

Aug. 30, 1996

Biomira licenses MAb-170 to Neoprobe

Aug. 30, 1996

Nymox Pharmaceuticals present positive results from AD7C trial

Aug. 23, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 16, 2025.
ADEL wins $1.04B Sanofi deal for tau-targeting Alzheimer’s drug
BioWorld
ADEL Inc. closed a year-end licensing deal worth up to $1.04 billion with Sanofi SA for ADEL-Y01, a specific tau-targeting Alzheimer’s disease drug candidate in a...
Neutrophils put the brakes on fat loss
BioWorld Science
Fat tissue balances energy by storing lipids during times of abundance and mobilizing them when needed, yet sustained metabolic stress demands mechanisms that...
Radiopharm Theranostics’ RAD-101 meets brain metastases endpoints
BioWorld
Radiopharm Theranostics Ltd.’s radiotracer RAD-101 met the primary endpoint in 92% of patients in the phase IIb imaging trial in brain metastases, according to...